Biocorrx Inc. (OTCMKTS:BICX – Get Free Report) passed below its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.38 and traded as low as $0.3790. Biocorrx shares last traded at $0.3790, with a volume of 110 shares.
Biocorrx Stock Performance
The firm has a market capitalization of $11.01 million, a P/E ratio of -2.37 and a beta of 0.17. The business has a 50 day simple moving average of $0.38 and a two-hundred day simple moving average of $0.35.
Biocorrx (OTCMKTS:BICX – Get Free Report) last announced its earnings results on Friday, May 15th. The company reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.03. The business had revenue of $0.22 million during the quarter, compared to the consensus estimate of $0.22 million.
Biocorrx Company Profile
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Further Reading
- Five stocks we like better than Biocorrx
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
